Health Canada | Santé Canada has opened a public consultation called the Special Access Program (SAP). The Special Access Program allows healthcare professionals to request drugs that are not available for sale in #Canada in cases where a patient has a serious or life-threatening condition.
This amendment would make #psychedelics, including #psilocybin and #MDMA, which are currently under the banner of ‘restricted drugs’, accessible via the SAP. This is an opportunity to support changes in Canadian regulatory framework that could save lives. The window to submit feedback to the government closes on February 10th, 2021.
Learn more here:
Send an email to:
with your ideas or comments.
Please share with your Canadian friends.